Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.38
+0.06 (0.64%)
Mar 19, 2026, 4:00 PM EDT - Market closed
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.31 billion as of March 19, 2026. Its market cap has increased by 16.37% in one year.
Market Cap
1.31B
Enterprise Value
939.51M
1-Year Change
16.37%
Ranking
Category
Stock Price
$9.38
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.31B, a decrease of -14.67%. That is a compound annual growth rate of -2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 1.49B | 77.54% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 1.34B |
| Palvella Therapeutics | 1.33B |
| MBX Biosciences | 1.32B |
| Ardelyx | 1.32B |
| Zenas BioPharma | 1.31B |
| Taysha Gene Therapies | 1.30B |
| Immatics | 1.30B |
| Rapport Therapeutics | 1.28B |